Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05154955 · ClinicalTrials.gov registry record · Phase 2
A Safety and Tolerability Study of 10XB-101 Injection in Adult Subjects With Submental Fat
A Phase 2 study, sponsored by 10xBio.
- Completed
- Registry status
- Phase 2
- Development phase
- 51
- Enrollment target
NCT05154955: Completed Phase 2 study, sponsored by 10xBio.
NCT05154955 is a Phase 2 study that has completed, run by 10xBio. The registered enrollment target is 51 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (62% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05154955, a Phase 2 study, has completed, sponsored by 10xBio.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 51 participants
- Enrollment target
Study Summary
The purpose of this research study is to determine the safety and efficacy of 10XB-101 vs. vehicle (placebo) for adults with excessive submental fat (SMF).
Interventions
- DRUG 10XB-101 Solution for Injection
- DRUG 10XB-101 Vehicle Solution for Injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2021-10-19 |
| Est. Completion | 2024-03-19 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05154955
The ClinicalTrials.gov registry entry for NCT05154955 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (62% lower). The listed sponsor is 10xBio, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 10XB-101 Solution for Injection is the first listed.
NCT05154955 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05154955 about?
NCT05154955 is a clinical study titled "A Safety and Tolerability Study of 10XB-101 Injection in Adult Subjects With Submental Fat". The purpose of this research study is to determine the safety and efficacy of 10XB-101 vs. vehicle (placebo) for adults with excessive submental fat (SMF).
What is the current status of trial NCT05154955?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 51 participants. The study started on 2021-10-19. Estimated completion is 2024-03-19.
What interventions are being tested in trial NCT05154955?
The interventions under investigation include: 10XB-101 Solution for Injection (DRUG), 10XB-101 Vehicle Solution for Injection (DRUG).
Who is sponsoring clinical trial NCT05154955?
This trial is sponsored by 10xBio, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.